![]() ![]() As a student with Howard Temin, he performed some of the initial studies defining subviral structures and their presence in cells as markers of infection. He joined Tufts in 1975.Ĭoffin’s scientific career has been centered on developing an understanding of the association of retroviruses with their hosts. John Coffin, PhD, is professor of molecular biology and microbiology at the School of Medicine. In addition, the holder takes an active part in teaching medical students and post-graduate medical students in his or her special fields of competence and helps in the coordination and integration of cancer teaching.Īmerican Cancer Society Research Professorship The professorship is held by a senior faculty researcher whose research focuses on the field of cellular differentiation and growth and leads to the better understanding of cellular processes, including those aberrant processes which contribute to cancer. Founded in 1913, the ACS is dedicated to eliminating cancer as a major health problem. This professorship was established in 1968 by the American Cancer Society (ACS)'s Massachusetts Division. Heldwein is an editorial board member of Virology and the Journal of Virology and is a member of the VIRA (Virology A) Study Section at NIH. She has also received several teaching awards from Tufts. In 2016, Heldwein was named a Howard Hughes Medical Institute Faculty Scholar, and in 2019, she was elected a Fellow of the American Academy of Microbiology. Heldwein has received several accolades for her research, including the Pew Biomedical Scholar Award, the National Institutes of Health (NIH)’s Director’s New Innovator Award, the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award, the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) Young Investigator Award, and the Merck Irving S. She is also a co-founder of Thyreos LLC, a startup that focuses on developing vaccines against neurotropic herpesviruses. Her recent work on deciphering the structural basis for how herpesviruses control their movement in nerve cells has led to a patent that covers the use of this technology in herpesvirus vaccination and oncolytic vector therapy. ![]() Early in her career, Heldwein made a breakthrough discovery in how herpesviruses penetrate their host cells to establish infection that was published in Science. Heldwein also employs structural biology to determine the three-dimensional structures of herpesviral proteins. Her laboratory uses a multidisciplinary approach that combines the power of biophysics, cell biology, virology, and biochemistry. Heldwein’s lab investigates how herpesviral particles enter their target cells and move within them to establish infection, and how progeny herpesviral particles assemble and exit the cell to infect new cells and hosts. She earned her PhD in biochemistry from the Oregon Health and Sciences University (OHSU) and completed her postdoctoral fellowship at Harvard Medical School. Ekaterina (Katya) Heldwein, PhD, is professor of molecular biology and microbiology at the School of Medicine. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |